Barinthus Biotherapeutics plc. — Director's Dealing 2021

May 3, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vaccitech plc (VACC)
CIK: 0001828185
Period of Report: 2021-04-29

Reporting Person: M&G INVESTMENT MANAGEMENT LTD (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
American Depositary Shares	963597.00	Indirect

Footnotes

F1: Each representing one ordinary share.

F2: The reported securities are held directly by M&G ACS, advised by M&G Investment Management Limited. The reported securities may be deemed beneficially owned for the purposes of Section 13(d) of the Securities Exchange Act 1934 by M&G Investment Management Limited as investment manager to these funds. The Reporting Person disclaims beneficial ownership of the securities for purposes of Rule 16a-1(a)(2) and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.